Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity
Cyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 10, Iss. 1, pp. 34-39
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy
Huige Zhou, Fenglan Qin, Chunying Chen
Advanced Healthcare Materials (2020) Vol. 10, Iss. 5
Closed Access | Times Cited: 48
Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113606-113606
Closed Access | Times Cited: 31
Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents
Prisca Lagardère, Cyril Fersing, Nicolas Masurier, et al.
Pharmaceuticals (2021) Vol. 15, Iss. 1, pp. 35-35
Open Access | Times Cited: 30
Synthetic and medicinal perspective of antileishmanial agents: An overview
Swati Pawar, Mukesh Kumar Kumawat, Monika Kundu, et al.
Journal of Molecular Structure (2022) Vol. 1271, pp. 133977-133977
Closed Access | Times Cited: 17
Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases
Andreina Henriquez-Figuereo, Cristina Morán-Serradilla, Eduardo Angulo-Elizari, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 115002-115002
Open Access | Times Cited: 16
Privileged small molecules against neglected tropical diseases: A perspective from structure activity relationships
Jafar Abbasi Shiran, Babak Kaboudin, Nasrin Panahi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116396-116396
Closed Access | Times Cited: 2
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues
Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, et al.
RSC Advances (2020) Vol. 10, Iss. 63, pp. 38328-38343
Open Access | Times Cited: 26
Nitro compounds against trypanosomatidae parasites: Heroes or villains?
Paulo Fernando da Silva Santos-Júnior, Leandro Rocha Silva, Lucindo José Quintans‐Júnior, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 75, pp. 128930-128930
Closed Access | Times Cited: 13
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi
Cyril Fersing, Clotilde Boudot, Caroline Castera‐Ducros, et al.
European Journal of Medicinal Chemistry (2020) Vol. 202, pp. 112558-112558
Open Access | Times Cited: 18
Antileishmanial and cytotoxic activities of ionic surfactants compared to those of miltefosine
Laís Alonso, Éder Jéferson Souza Cardoso, Rodrigo Saar Gomes, et al.
Colloids and Surfaces B Biointerfaces (2019) Vol. 183, pp. 110421-110421
Closed Access | Times Cited: 18
Sojourn of Nitrogenous Heterocycles as Promising Antileishmanial Agents: Medicinal Perspectives and Structure–Activity Relationship Studies
Bhupender Nehra, Manoj Kumar, Sumitra Singh, et al.
Chemistry Africa (2024) Vol. 7, Iss. 7, pp. 3485-3529
Closed Access | Times Cited: 1
Synthesis and antileishmanial activity of fluorinated rhodacyanine analogues: The ‘fluorine-walk’ analysis
Thitiya Lasing, Atchara Phumee, Padet Siriyasatien, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 28, Iss. 1, pp. 115187-115187
Closed Access | Times Cited: 16
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties
Cyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112668-112668
Open Access | Times Cited: 13
Unveiling the relevance of the redox character of nitroaromatic and nitroheteroaromatic compounds as potential medicines
Jadriane A. Xavier, Thaissa L. Silva, Eduardo Caio Torres-Santos, et al.
Current Opinion in Electrochemistry (2021) Vol. 29, pp. 100740-100740
Closed Access | Times Cited: 12
Treating leishmaniasis in Amazonia, part 2: Multi-target evaluation of widely used plants to understand medicinal practices
Emeline Houël, Marine Ginouvès, Nadine Azas, et al.
Journal of Ethnopharmacology (2022) Vol. 289, pp. 115054-115054
Open Access | Times Cited: 8
Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents
Fanny Mathias, Anita Cohen, Youssef Kabri, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112146-112146
Open Access | Times Cited: 10
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore
Romain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade‐Delmas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 998-998
Open Access | Times Cited: 6
Synthesis and antibacterial activity in vitro of 2-benzylthioimidazo[1,2-a]pyridine derivatives against pathogenic bacterial
Ablo Evrard, Siomenan Coulibali, Daouda Touré, et al.
Synthetic Communications (2022) Vol. 52, Iss. 3, pp. 462-469
Closed Access | Times Cited: 6
Design and synthesis of imidazo[1,2‐a]pyridine‐chalcone conjugates as antikinetoplastid agents
Devesh S. Agarwal, Richard M. Beteck, Kayhan Ilbeigi, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 2
Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis
Jose Ignacio Escrig, Yukiko Miyamoto, Alejandro Delgado Aznar, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 68, Iss. 1
Open Access | Times Cited: 2
Synthesis of New 5- or 7-Substituted 3-Nitroimidazo[1,2-a]pyridine Derivatives Using SNAr and Palladium-Catalyzed Reactions To Explore Antiparasitic Structure–Activity Relationships
Nicolas Primas, Patrice Vanelle, Romain Paoli-Lombardo, et al.
Synthesis (2023) Vol. 56, Iss. 08, pp. 1297-1308
Open Access | Times Cited: 2
31st Annual GP2A Medicinal Chemistry Conference
Nicolas Primas, Caroline Castera‐Ducros, Romain Paoli-Lombardo, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 209-243
Open Access
Using 5-Nitroimidazole Derivatives against Neglected Tropical Protozoan Diseases: Systematic Review
Micheel Merari Vichi-Ramírez, Edgar López‐López, Catalina Soriano‐Correa, et al.
Future Pharmacology (2024) Vol. 4, Iss. 1, pp. 222-255
Open Access
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 878-878
Open Access
Structural simplification of the 3‐nitroimidazo[1,2‐a]pyridine antileishmanial pharmacophore: Design, synthesis, and antileishmanial activity of novel 2,4-disubstituted 5-nitroimidazoles
Romain Paoli-Lombardo, Nicolas Primas, Sébastien Hutter, et al.
Heterocyclic Communications (2024) Vol. 30, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top